FDA Policy Changes on Stability Studies for PET Drugs Manufactured Within Networks

TO THE EDITOR: During the process of developing a new PET drug and obtaining marketing authorization from the Food and Drug Administration (FDA), the stability of a product is assessed to ensure that the purity and quality meet (or exceed) specifications at both the time of release and expiration.